Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05694312
Title Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Age Groups: adult | senior
Covered Countries ITA

No variant requirements are available.